Shares of Clovis Oncology Inc (CLVS) are trading -11% lower at a price of $2.185 at the time of this writing.

Clovis Oncology Inc has been trading between a 52-week high of $5.3 and a 52-week low of $0.581. The stock has a market cap of $314 Million.

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops, with partners, for those indications that require them, diagnostic tools intended to direct a compound in development to the population that is most likely to benefit from its use.

Thinking about buying stock in Humanigen, Endo International, Kura Oncology, Delta Air Lines, or Clovis Oncology?
Benzinga 07-13-22

Clovis Oncology: Managing Winning Position After Recent Updates
Seeking Alpha 07-13-22

Stock Trending Alert: fuboTV Inc. (NYSE:FUBO), Clovis Oncology, Inc. (NASDAQ:CLVS)
Stock Equity 07-12-22

Clovis Oncology Inc. (NASDAQ: CLVS) Could See Prices Soar In The Coming Months
Marketing Sentinel 07-12-22

Clovis Oncology: Shares Pop And Drop Around FDA News (NASDAQ:CLVS)
Seeking Alpha 07-11-22